Glenmede Trust’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,210
Closed -$238K 1396
2024
Q3
$238K Buy
1,210
+105
+10% +$20.7K ﹤0.01% 1178
2024
Q2
$228K Buy
1,105
+18
+2% +$3.72K ﹤0.01% 1147
2024
Q1
$295K Buy
1,087
+49
+5% +$13.3K ﹤0.01% 1066
2023
Q4
$245K Buy
+1,038
New +$245K ﹤0.01% 1091
2023
Q1
Sell
-956
Closed -$208K 1299
2022
Q4
$208K Buy
+956
New +$208K ﹤0.01% 1088
2022
Q2
Sell
-831
Closed -$235K 1306
2022
Q1
$235K Buy
831
+48
+6% +$13.6K ﹤0.01% 1100
2021
Q4
$294K Sell
783
-511
-39% -$192K ﹤0.01% 1055
2021
Q3
$532K Buy
1,294
+22
+2% +$9.05K ﹤0.01% 892
2021
Q2
$470K Buy
1,272
+441
+53% +$163K ﹤0.01% 910
2021
Q1
$240K Sell
831
-107
-11% -$30.9K ﹤0.01% 1030
2020
Q4
$233K Sell
938
-16
-2% -$3.97K ﹤0.01% 1020
2020
Q3
$215K Sell
954
-141
-13% -$31.8K ﹤0.01% 1007
2020
Q2
$190K Sell
1,095
-111
-9% -$19.3K ﹤0.01% 1026
2020
Q1
$184K Hold
1,206
﹤0.01% 1218
2019
Q4
$184K Buy
1,206
+952
+375% +$145K ﹤0.01% 1218
2019
Q3
$33 Sell
254
-185
-42% -$24 ﹤0.01% 1839
2019
Q2
$62 Sell
439
-180
-29% -$25 ﹤0.01% 1579
2019
Q1
$89 Buy
619
+180
+41% +$26 ﹤0.01% 1449
2018
Q4
$48 Sell
439
-13,517
-97% -$1.48K ﹤0.01% 1607
2018
Q3
$1.88M Sell
13,956
-20,995
-60% -$2.82M 0.01% 654
2018
Q2
$3.92M Hold
34,951
0.02% 504
2018
Q1
$3.82M Hold
34,951
0.02% 536
2017
Q4
$3.82M Sell
34,951
-17
-0% -$1.86K 0.02% 536
2017
Q3
$3.78M Sell
34,968
-2,358
-6% -$255K 0.02% 529
2017
Q2
$3.36M Hold
37,326
0.02% 539
2017
Q1
$3.36M Sell
37,326
-6,779
-15% -$610K 0.02% 539
2016
Q4
$3.36M Sell
44,105
-15
-0% -$1.14K 0.02% 525
2016
Q3
$3.68M Hold
44,120
0.02% 515
2016
Q2
$3.64M Sell
44,120
-1,679
-4% -$138K 0.02% 509
2016
Q1
$3.48M Buy
45,799
+160
+0.4% +$12.1K 0.02% 498
2015
Q4
$3.67M Sell
45,639
-75
-0.2% -$6.03K 0.03% 486
2015
Q3
$2.9M Buy
45,714
+7,027
+18% +$446K 0.02% 513
2015
Q2
$2.72M Buy
38,687
+3,925
+11% +$276K 0.02% 506
2015
Q1
$2.76M Buy
34,762
+122
+0.4% +$9.67K 0.02% 529
2014
Q4
$2.2M Hold
34,640
0.02% 551
2014
Q3
$2.07M Buy
34,640
+23,940
+224% +$1.43M 0.02% 548
2014
Q2
$572K Buy
+10,700
New +$572K 0.01% 826